BR9909189A - Suspensão de agente ativo peroral - Google Patents

Suspensão de agente ativo peroral

Info

Publication number
BR9909189A
BR9909189A BR9909189-5A BR9909189A BR9909189A BR 9909189 A BR9909189 A BR 9909189A BR 9909189 A BR9909189 A BR 9909189A BR 9909189 A BR9909189 A BR 9909189A
Authority
BR
Brazil
Prior art keywords
suspension
active agent
peroral
small amounts
peroral active
Prior art date
Application number
BR9909189-5A
Other languages
English (en)
Inventor
Dietrick Tuerck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR9909189A publication Critical patent/BR9909189A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"SUSPENSãO DE AGENTE ATIVO PERORAL"<D>. A presente invenção refere-se suspensões administradas oralmente de substâncias ativas farmacêuticas do tipo NSAID, particularmente o agente anti-reumático meloxicam, as quais são estabilizadas pela adição de pequenas quantidades de dióxido de silício altamente disperso usando altas forças de cisalhamento e adicionando pequenas quantidades de polímeros hidrófilos para formar uma estrutura silóide tridimensional, e um processo para a preparação do mesmo.
BR9909189-5A 1998-03-27 1999-03-23 Suspensão de agente ativo peroral BR9909189A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (de) 1998-03-27 1998-03-27 Perorale Wirkstoff-Suspension
PCT/EP1999/001948 WO1999049845A1 (de) 1998-03-27 1999-03-23 Perorale wirkstoff-suspension

Publications (1)

Publication Number Publication Date
BR9909189A true BR9909189A (pt) 2000-12-05

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909189-5A BR9909189A (pt) 1998-03-27 1999-03-23 Suspensão de agente ativo peroral

Country Status (26)

Country Link
EP (2) EP0945131A1 (pt)
JP (1) JP3323189B2 (pt)
KR (1) KR100587208B1 (pt)
CN (1) CN1150888C (pt)
AR (1) AR016196A1 (pt)
AT (1) ATE225648T1 (pt)
AU (1) AU762464B2 (pt)
BR (1) BR9909189A (pt)
CA (1) CA2326048C (pt)
CO (1) CO5070601A1 (pt)
DE (1) DE59903023D1 (pt)
DK (1) DK1066029T3 (pt)
ES (1) ES2184428T3 (pt)
HK (1) HK1034184A1 (pt)
HU (1) HU228474B1 (pt)
IL (1) IL137479A (pt)
MY (1) MY124599A (pt)
NO (1) NO321401B1 (pt)
NZ (1) NZ507610A (pt)
PL (1) PL192969B1 (pt)
PT (1) PT1066029E (pt)
TR (1) TR200002772T2 (pt)
TW (1) TWI232759B (pt)
UY (1) UY25443A1 (pt)
WO (1) WO1999049845A1 (pt)
ZA (1) ZA200003951B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
AU2005313365A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
GB2438287A (en) 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
EP2488145B1 (en) * 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
EP2544660B1 (en) * 2010-03-10 2018-06-13 Lupin Limited Rifaximin ready-to-use suspension
NZ701237A (en) * 2010-03-19 2016-04-29 Boston Biomedical Inc Novel compounds and compositions for targeting cancer stem cells
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
WO2014097685A1 (ja) * 2012-12-19 2014-06-26 三菱電機株式会社 空気調和機
CN107529789A (zh) 2015-04-28 2018-01-02 马斯公司 制备灭菌湿宠物食品的方法
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
CN112044605B (zh) * 2019-06-06 2022-06-21 钟志勇 选钛药剂及选钛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
CO5070601A1 (es) 2001-08-28
CN1150888C (zh) 2004-05-26
TR200002772T2 (tr) 2000-12-21
JP3323189B2 (ja) 2002-09-09
HK1034184A1 (en) 2001-10-19
AR016196A1 (es) 2001-06-20
MY124599A (en) 2006-06-30
KR100587208B1 (ko) 2006-06-08
CA2326048C (en) 2008-08-12
CN1295462A (zh) 2001-05-16
NO321401B1 (no) 2006-05-08
IL137479A (en) 2005-09-25
PL192969B1 (pl) 2006-12-29
CA2326048A1 (en) 1999-10-07
ATE225648T1 (de) 2002-10-15
UY25443A1 (es) 1999-11-17
JP2002509875A (ja) 2002-04-02
IL137479A0 (en) 2001-07-24
ZA200003951B (en) 2002-01-18
NO20004822D0 (no) 2000-09-26
EP1066029B1 (de) 2002-10-09
AU3147099A (en) 1999-10-18
NO20004822L (no) 2000-11-23
WO1999049845A1 (de) 1999-10-07
ES2184428T3 (es) 2003-04-01
PL342345A1 (en) 2001-06-04
EP0945131A1 (de) 1999-09-29
DK1066029T3 (da) 2003-01-27
NZ507610A (en) 2003-08-29
HU228474B1 (en) 2013-03-28
HUP0102036A3 (en) 2002-12-28
TWI232759B (en) 2005-05-21
HUP0102036A2 (hu) 2002-03-28
EP1066029A1 (de) 2001-01-10
DE59903023D1 (en) 2002-11-14
KR20010042197A (ko) 2001-05-25
AU762464B2 (en) 2003-06-26
PT1066029E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
BR9909189A (pt) Suspensão de agente ativo peroral
BR0211736A (pt) Formulação para suspensão oral estabilizada
BR0211028A (pt) Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto
BR9812018A (pt) Composições farmacêuticas de meloxicam com solubilidade e biodisponibilidade melhoradas
BR9908488A (pt) Composição farmacêutica de topiramato
BRPI0411678A (pt) nanopartìculas de ácido hialurÈnico
ATE429210T1 (de) Orale flüssige zusammensetzungen
WO2004087052A3 (en) Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
BR0215238A (pt) Uso de nanopartìculas inor ânicas sintéticas como veìculos para drogas oftálmicas e óticas
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
BR0208605A (pt) Suspensão coloidal de nanopartìculas à base de copolìmero anfìfilo, para a vetorização de princìpios ativos
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
ATE478841T1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
BRPI0009299A (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
NO20054787D0 (no) Indenderivater som farmasotiske midler
KR950703942A (ko) 아토바큐온 약학적 조성물(atovauone pharmaceutical compositions)
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
MA27670A1 (fr) Composition pharmaceutique contenant de l&#39;acide 5-methyl-2-2&#39;-(chloro-6&#39;-fluoroanilino)phenylacetique
BR0112337A (pt) Derivados de fosfolipìdeos de ácido valpróico e suas misturas
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
BRPI0417782A (pt) sìlica de precipitação, processo de preparação de uma sìlica, e, utilização de uma sìlica
BR0008713A (pt) Processos para preparar formulações ecomposições farmacêuticas orais com ecb
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/00, A61K 47/02, A61P 29/00

Ipc: A61K 9/00 (2009.01), A61K 47/02 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]